Schonfeld Strategic Advisors’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,100
Closed -$21.7K 2400
2025
Q1
$21.7K Buy
+13,100
New +$21.6K ﹤0.01% 2102
2024
Q3
Sell
-264,973
Closed -$331K 2319
2024
Q2
$331K Buy
+264,973
New +$344K ﹤0.01% 1643
2023
Q3
Sell
-58,157
Closed -$126K 2148
2023
Q2
$126K Sell
58,157
-30,843
-35% -$48.3K ﹤0.01% 1679
2023
Q1
$130K Sell
89,000
-266,951
-75% -$344K ﹤0.01% 1641
2022
Q4
$445K Sell
355,951
-122,427
-26% -$193K ﹤0.01% 1596
2022
Q3
$904K Buy
478,378
+204,183
+74% +$483K 0.01% 1333
2022
Q2
$694K Buy
274,195
+233,595
+575% +$681K 0.01% 1194
2022
Q1
$139K Buy
+40,600
New +$143K ﹤0.01% 2128
2021
Q2
Sell
-44,810
Closed -$192K 2202
2021
Q1
$192K Buy
+44,810
New +$214K ﹤0.01% 1528
2020
Q3
Sell
-59,305
Closed -$203K 1566
2020
Q2
$203K Buy
+59,305
New +$133K 0.01% 1105
2016
Q2
Sell
-13,609
Closed -$141K 504
2016
Q1
$141K Buy
+13,609
New +$124K 0.06% 281

Other funds holding OPK

Schonfeld Strategic Advisors's OPK Position: Q2 2025 in Review

Schonfeld Strategic Advisors sold out of Opko Health (OPK) in Q2 2025, closing a stake of 13,100 shares — an estimated $21.7K sold.

Schonfeld Strategic Advisors first reported a position in OPK in Q1 2016 and held it in 11 quarters. The position peaked at $904K in Q3 2022. 222 funds tracked by Wall St. Rank hold OPK as of Q2 2025.

  • Schonfeld Strategic Advisors reported no remaining Opko Health position as of Q2 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 13,100 Opko Health shares in Q2 2025, an estimated $21.7K.
  • Schonfeld Strategic Advisors first reported a position in Opko Health in Q1 2016 and held it in 11 quarters.
  • Schonfeld Strategic Advisors's Opko Health position peaked at $904K in Q3 2022.
  • 222 funds tracked by Wall St. Rank held Opko Health as of Q2 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.